Sports Medicine

, Volume 37, Issue 4–5, pp 361–363 | Cite as

Exertional Rhabdomyolysis and Acute Renal Failure in Marathon Runners

Conference Paper

Abstract

Strenuous exercise, including marathon running, can result in damage to skeletal muscle cells, a process known as exertional rhabdomyolysis. In most cases, this damage is resolved without consequence. However, when the damage is profound, there is a release of muscle proteins into the blood; one of these proteins, myoglobin, in high concentrations and under certain conditions (such as dehydration and heat stress) can precipitate in the kidneys, thereby resulting in acute renal failure. Although the marathon is a gruelling physiological challenge, with races sometimes run in hot and humid weather, acute renal failure is relatively infrequent. From case reports, a high proportion of marathon runners who developed acute renal failure had taken analgesics, had a viral or bacterial infection, or a pre-existing condition. The rare cases of acute renal failure in marathon runners may be a situation of the ‘perfect storm’ where there are several factors (heat stress, dehydration, latent myopathy, non-steroidal anti-inflammatory or other drug/analgesic use, and viral/bacterial infection) that, in some combination, come together to result in acute renal failure.

References

  1. 1.
    Clarkson PM, Hubal MJ. Exercise-induced muscle damage in humans. Am J Phys Med Rehabil 2002; 81: 552–69CrossRefGoogle Scholar
  2. 2.
    Clarkson PM, Kearns AK, Ronner P, et al. Serum creatine kinase levels and renal function measures in exertional muscle damage. Med Sci Sports Exerc 2006; 38: 623–7PubMedCrossRefGoogle Scholar
  3. 3.
    Clarkson PM, Eichner ER. Exertional rhabdonryolysis: does elevated blood creatine kinase foretell renal failure? Curr Sports Med Rep 2006; 5: 57–60PubMedGoogle Scholar
  4. 4.
    Seedat YK, Aboo N, Naicker S, et al. Acute renal failure in the “Comrades Marathon” runners. Ren Fail 1989; 11: 209–12PubMedCrossRefGoogle Scholar
  5. 5.
    Schiff HB, MacSearraigh ET, Kallmeyer JC. Myoglobinmia, rhabdomyolysis and marathon running. Q J Med 1978; 47: 463–72PubMedGoogle Scholar
  6. 6.
    MacSearraigh ET, Kallmeyer JC, Schiff HB. Acute renal failure in marathon runners. Nephron 1979; 24: 236–40PubMedCrossRefGoogle Scholar
  7. 7.
    Vining KE, Nichols NJ, Seligson GR. Naproxen and acute renal failure in a runner [letter]. Ann Intern Med 1986; 105: 144Google Scholar
  8. 8.
    Lonka L, Pedersen RS. Fatal rhabdomyolysis in marathon runner. Lancet 1987; I: 857–8CrossRefGoogle Scholar
  9. 9.
    Boyd JF. Fatal rhabdomyolysis in a marathon runner. Lancet 1987; 1: 1089PubMedCrossRefGoogle Scholar
  10. 10.
    Reid WA, McQueen A. Acute rhabdomyolysis in a marathon runner [letter]. Br J Sports Med 1987; 21: 49PubMedCrossRefGoogle Scholar
  11. 11.
    Farquhar B, Kenney LW. Anti-inflammatory drugs, kidney function, and exercise. Sports Science Exchange 1997; 11: 1–5Google Scholar
  12. 12.
    Testa M, Navazio FM, Neugebauer J. Recognition, diagnosis, and treatment of mitochondrial myopattues in endurance athletes. Curr Sports Med Rep 2005; 4: 282–7PubMedGoogle Scholar
  13. 13.
    Ratliff NB, Harris KM, Smith SA, et al. Cardiac arrest in a young marathon runner. Lancet 2002; 360: 542PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2007

Authors and Affiliations

  1. 1.Kinesiology DepartmentUniversity of MassachusettsAmherstUSA

Personalised recommendations